Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Olmesartan Medoxomil Tablets Under Fed Conditions

NCT03319706 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

34

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Subjects

Interventions

DRUG: Torrent's Olmesartan Medoxomil Tablets 40 mg
DRUG: Daiichi Sankyo Inc's Benicar Tablets 40 mg

Sponsor

Torrent Pharmaceuticals Limited